![](/img/cover-not-exists.png)
Phase II Trial of Tipifarnib plus Neoadjuvant Doxorubicin-Cyclophosphamide in Patients with Clinical Stage IIB-IIIC Breast Cancer
Sparano, J. A., Moulder, S., Kazi, A., Coppola, D., Negassa, A., Vahdat, L., Li, T., Pellegrino, C., Fineberg, S., Munster, P., Malafa, M., Lee, D., Hoschander, S., Hopkins, U., Hershman, D., Wright,Volume:
15
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-08-2658
Date:
April, 2009
File:
PDF, 275 KB
english, 2009